{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:47:11Z","timestamp":1763016431552},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,1,1]]},"DOI":"10.1038\/sj.bmt.1704334","type":"journal-article","created":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T08:10:03Z","timestamp":1070266203000},"page":"197-204","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Influence of cytomegalovirus (CMV) sero-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: a comparison between two T-cell depletion regimens"],"prefix":"10.1038","volume":"33","author":[{"given":"S","family":"Chakrabarti","sequence":"first","affiliation":[]},{"given":"D W","family":"Milligan","sequence":"additional","affiliation":[]},{"given":"J","family":"Brown","sequence":"additional","affiliation":[]},{"given":"H","family":"Osman","sequence":"additional","affiliation":[]},{"given":"I B","family":"Vipond","sequence":"additional","affiliation":[]},{"given":"D H","family":"Pamphilon","sequence":"additional","affiliation":[]},{"given":"D I","family":"Marks","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2003,12,1]]},"reference":[{"key":"BF1704334_CR1","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V83.7.1971.1971","volume":"83","author":"CR Li","year":"1994","unstructured":"Li CR, Greenberg PD, Gilbert MJ et al. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994; 83: 1971\u20131979.","journal-title":"Blood"},{"key":"BF1704334_CR2","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1086\/515146","volume":"28","author":"Q Nguyen","year":"1999","unstructured":"Nguyen Q, Champlin R, Giralt S et al. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow recipients. Clin Infect Dis 1999; 28: 618\u2013623.","journal-title":"Clin Infect Dis"},{"key":"BF1704334_CR3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/sj.bmt.1702226","volume":"25","author":"H Einsele","year":"2000","unstructured":"Einsele H, Hebart H, Kauffmann-Schneider C et al. Risk factors for treatment failures in patients receiving PCR-based pre-emptive therapy for CMV infection. Bone Marrow Transplant 2000; 25: 757\u2013763.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704334_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1046\/j.1365-2141.2002.03515.x","volume":"118","author":"P Ljungman","year":"2002","unstructured":"Ljungman P . Prevention and treatment of viral infections in stem cell transplant recipients. Br J Haematol 2002; 118: 44\u201357.","journal-title":"Br J Haematol"},{"key":"BF1704334_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1182\/blood.V97.2.388","volume":"97","author":"P Ljungman","year":"2001","unstructured":"Ljungman P, Deliliers GL, Platzbecker U et al. Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood 2001; 97: 388\u2013392.","journal-title":"Blood"},{"key":"BF1704334_CR6","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1182\/blood.V97.5.1232","volume":"97","author":"K Cwynarski","year":"2001","unstructured":"Cwynarski K, Ainsworth J, Cobbold M et al. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 2001; 97: 1232\u20131240.","journal-title":"Blood"},{"key":"BF1704334_CR7","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","volume":"99","author":"H Einsele","year":"2002","unstructured":"Einsele H, Roosnek E, Rufer N et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002; 99: 3916\u20133922.","journal-title":"Blood"},{"key":"BF1704334_CR8","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V95.7.2240","volume":"95","author":"AE Broers","year":"2000","unstructured":"Broers AE, van Der Holt R, van Essen JW et al. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood 2000; 95: 2240\u20132245.","journal-title":"Blood"},{"key":"BF1704334_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1365-2141.2001.02519.x","volume":"112","author":"C Craddock","year":"2000","unstructured":"Craddock C, Szydlo RM, Dazzi F et al. Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis. Br J Haematol 2000; 112: 228\u2013236.","journal-title":"Br J Haematol"},{"key":"BF1704334_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1046\/j.1365-2141.2001.02849.x","volume":"113","author":"N Kroger","year":"2001","unstructured":"Kroger N, Zabelina T, Kruger W et al. Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin. Br J Haematol 2001; 113: 1060\u20131071.","journal-title":"Br J Haematol"},{"key":"BF1704334_CR11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/infdis\/153.3.478","volume":"153","author":"JD Meyers","year":"1986","unstructured":"Meyers JD, Flournoy N, Thomas ED . Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153: 478\u2013488.","journal-title":"J Infect Dis"},{"key":"BF1704334_CR12","first-page":"461","volume":"13","author":"D Przepiorka","year":"1994","unstructured":"Przepiorka D, Ippoliti C, Panina A et al. Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation. Bone Marrow Transplant 1994; 13: 461\u2013464.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704334_CR13","first-page":"347","volume":"18","author":"D Couriel","year":"1996","unstructured":"Couriel D, Canosa J, Engler H et al. Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies. Bone Marrow Transplant 1996; 18: 347\u2013353.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704334_CR14","first-page":"387","volume":"15","author":"B Hertenstein","year":"1995","unstructured":"Hertenstein B, Hampl W, Bunjes D et al. In vivo\/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT. Bone Marrow Transplant 1995; 15: 387\u2013393.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704334_CR15","first-page":"1075","volume":"86","author":"R Martino","year":"2001","unstructured":"Martino R, Rovira M, Carreras E et al. The AlloPBSCT and Infectious\/Non-infectious Complications Subcommittes of the Grupo Espanol de Trasplante Hematopoyetico (GETH). Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation. Haematologica 2001; 86: 1075\u20131086.","journal-title":"Haematologica"},{"key":"BF1704334_CR16","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1182\/blood.V97.7.2183","volume":"97","author":"H Hebart","year":"2001","unstructured":"Hebart H, Brugger W, Grigoleit U et al. Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based pre-emptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality. Blood 2001; 97: 2183\u20132185.","journal-title":"Blood"},{"key":"BF1704334_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/sj.bmt.1704082","volume":"32","author":"S Chakrabarti","year":"2003","unstructured":"Chakrabarti S, Brown J, Guttridge M et al. Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T cell addback. Bone Marrow Transplant 2003; 32: 23\u201330.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704334_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1046\/j.1365-2141.2003.04228.x","volume":"121","author":"S Chakrabarti","year":"2003","unstructured":"Chakrabarti S, MacDonald D, Hale G et al. T cell depletion with Campath-1H \u2018in the bag\u2019 for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survival. Br J Haematol 2003; 121: 109\u2013118.","journal-title":"Br J Haematol"},{"key":"BF1704334_CR19","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1182\/blood.V99.12.4357","volume":"99","author":"S Chakrabarti","year":"2002","unstructured":"Chakrabarti S, Mackinnon S, Chopra R et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood 2002; 99: 4357\u20134363.","journal-title":"Blood"},{"key":"BF1704334_CR20","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/sj.bmt.1703216","volume":"28","author":"S Chakrabarti","year":"2001","unstructured":"Chakrabarti S, Collingham KE, Fegan CD et al. Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections. Bone Marrow Transplant 2001; 28: 759\u2013763.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704334_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BF1704334_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204\u2013217.","journal-title":"Am J Med"},{"key":"BF1704334_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/146532401753174098","volume":"3","author":"G Hale","year":"2001","unstructured":"Hale G . The CD52 antigen and development of the CAMPATH antibodies. Cytotherapy 2001; 3: 137\u2013143.","journal-title":"Cytotherapy"},{"key":"BF1704334_CR24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood.V93.2.467","volume":"93","author":"TN Small","year":"1999","unstructured":"Small TN, Papadopoulos EB, Boulad F et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999; 93: 467\u2013480.","journal-title":"Blood"},{"key":"BF1704334_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/146532401317070899","volume":"3","author":"P Rebello","year":"2002","unstructured":"Rebello P, Cwynarsky K, Varughese M et al. Pharmacokinetics of Campath-1H in bone marrow transplant patients. Cytotherapy 2002; 3: 261\u2013267.","journal-title":"Cytotherapy"},{"key":"BF1704334_CR26","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood-2002-02-0377","volume":"100","author":"S Chakrabarti","year":"2002","unstructured":"Chakrabarti S, Mautner V, Osman H et al. Adenovirus infections following allogeneic stem cell transplantation: the incidence and outcome in relation to graft manipulation, immunosuppression and immune recovery. Blood 2002; 100: 1619\u20131627.","journal-title":"Blood"},{"key":"BF1704334_CR27","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1097\/00007890-200110270-00024","volume":"72","author":"S Chakrabarti","year":"2001","unstructured":"Chakrabarti S, Collingham KE, Marshall T et al. Respiratory virus infections in adult T cell-depleted transplant recipients: the role of cellular immunity. Transplantation 2001; 72: 1460\u20131463.","journal-title":"Transplantation"},{"key":"BF1704334_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/sj.bmt.1703847","volume":"31","author":"S Chakrabarti","year":"2003","unstructured":"Chakrabarti S, Osman H, Collingham K et al. Polyoma viruria in stem cell transplant recipients T cell depleted with Campath-1H: the incidence and outcome in relation to graft manipulation, donor type and conditioning. Bone Marrow Transplant 2003; 31: 379\u2013386.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704334_CR29","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/sj.bmt.1703248","volume":"28","author":"R Chakraverty","year":"2001","unstructured":"Chakraverty R, Robinson S, Peggs K et al. Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation. Bone Marrow Transplant 2001; 28: 827\u2013834.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704334_CR30","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0140-6736(87)92800-5","volume":"1","author":"JP Grob","year":"1987","unstructured":"Grob JP, Grundy JE, Prentice HG et al. Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections. Lancet 1987; 1: 774\u2013776.","journal-title":"Lancet"},{"key":"BF1704334_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00007890-200207150-00009","volume":"74","author":"TS Lin","year":"2002","unstructured":"Lin TS, Zahrieh D, Weller E et al. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation. Transplantation 2002; 74: 49\u201354.","journal-title":"Transplantation"},{"key":"BF1704334_CR32","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood.V86.7.2815.2815","volume":"86","author":"H Einsele","year":"1995","unstructured":"Einsele H, Ehninger G, Hebart H et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995; 86: 2815\u20132820.","journal-title":"Blood"},{"key":"BF1704334_CR33","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1182\/blood.V99.4.1159","volume":"99","author":"P Reusser","year":"2002","unstructured":"Reusser P, Einsele H, Lee J et al. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Randomized multicenter trial of foscarnet versus ganciclovir for pre-emptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 2002; 99: 1159\u20131164.","journal-title":"Blood"},{"key":"BF1704334_CR34","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1046\/j.1365-2141.1999.01229.x","volume":"104","author":"EC Williamson","year":"1999","unstructured":"Williamson EC, Millar MR, Steward CG et al. Infections in adults undergoing unrelated donor bone marrow transplantation. Br J Haematol 1999; 104: 560\u2013568.","journal-title":"Br J Haematol"},{"key":"BF1704334_CR35","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","volume":"100","author":"KA Marr","year":"2002","unstructured":"Marr KA, Carter RA, Boeckh M et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358\u20134366.","journal-title":"Blood"},{"issue":"Suppl.","key":"BF1704334_CR36","first-page":"S32","volume":"29","author":"GU Grigoleit","year":"2002","unstructured":"Grigoleit GU, Riegler S, Hebart H et al. Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocytes-derived immature dendritic cells. Bone Marrow Transplant 2002; 29 (Suppl.): S32.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704334_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7326\/0003-4819-118-3-199302010-00004","volume":"118","author":"DJ Winston","year":"1993","unstructured":"Winston DJ, Ho WG, Bartoni K et al. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial. Ann Intern Med 1993; 118: 179\u2013184.","journal-title":"Ann Intern Med"},{"issue":"Suppl.","key":"BF1704334_CR38","first-page":"S32","volume":"29","author":"P Ljungman","year":"2002","unstructured":"Ljungman P, Brand R, Einsele H et al. Donor CMV serological status influences the outcome after unrelated donor stem cell transplantation; an EBMT Megafile analysis. Bone Marrow Transplant 2002; 29 (Suppl.): S32.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704334","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:58:01Z","timestamp":1648079881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,1]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,1,1]]}},"alternative-id":["BF1704334"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704334","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,1]]},"assertion":[{"value":"12 June 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}